We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

97 hedge funds and large institutions have $209M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

9% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 34

10% less funds holding

Funds holding: 10897 (-11)

20% less capital invested

Capital invested by funds: $261M → $209M (-$52.1M)

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

80% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $6.06M

Holders
97
Holders Change
-11
Holders Change %
-10.19%
% of All Funds
2.58%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
17
Increased
31
Reduced
34
Closed
28
Calls
$1.22M
Puts
$6.06M
Net Calls
-$4.83M
Net Calls Change
+$1.87M
Name Holding Trade Value Shares
Change
Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.33M +$13.7K +3,400 +1%
BA
27
BlackRock Advisors
Delaware
$1.24M -$74.6K -18,562 -6%
TCIM
28
TIAA CREF Investment Management
New York
$1.15M -$37.1K -9,231 -4%
GC
29
Globeflex Capital
California
$1.1M +$114K +28,452 +14%
PAMU
30
Pictet Asset Management (UK)
United Kingdom
$821K
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$784K +$85.8K +21,352 +14%
HCMT
32
Highland Capital Management (Texas)
Texas
$781K +$682K +169,600 New
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$771K +$674K +167,700 New
TI
34
Turner Investments
Pennsylvania
$741K +$648K +161,100 New
PP
35
PDT Partners
New York
$731K +$255K +63,400 +66%
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$686K -$5.05M -1,255,744 -89%
UBS Group
37
UBS Group
Switzerland
$636K -$31.7K -7,881 -5%
VEA
38
Virtus ETF Advisers
New York
$584K +$510K +126,869 New
TA
39
Teachers Advisors
New York
$559K
Swiss National Bank
40
Swiss National Bank
Switzerland
$557K +$99.3K +24,700 +25%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$548K -$266K -66,226 -36%
AllianceBernstein
42
AllianceBernstein
Tennessee
$504K -$47K -11,700 -10%
Parallax Volatility Advisers
43
Parallax Volatility Advisers
California
$501K +$382K +95,000 +680%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$491K -$26.1K -6,500 -6%
ARTA
45
A.R.T. Advisors
New York
$488K -$424K -105,500 -50%
QIM
46
Quantitative Investment Management
Virginia
$390K +$341K +84,900 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$377K -$80 -20 -0%
Citigroup
48
Citigroup
New York
$363K +$229K +56,858 +260%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$338K
ProShare Advisors
50
ProShare Advisors
Maryland
$336K -$29K -7,206 -9%

RPTP Hedge Fund Activity: Q1 2016 in Review

97 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q1 2016, worth a combined $209M — down 20% from $261M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of RPTP and 17 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 31 added.

The largest buyer was Broadfin Capital, adding an estimated $18.4M. The largest seller was Credit Suisse, exiting entirely with an estimated $29.6M sold.

  • 97 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q1 2016, down from 108 in Q4 2015.
  • Funds reported $209M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q1 2016, down 20% quarter-over-quarter.
  • 17 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q1 2016 and 28 closed out, a net change of -11 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q1 2016 was Broadfin Capital, an estimated $18.4M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q1 2016 was Credit Suisse, an estimated $29.6M sold.

Based on aggregated 13F filings for Q1 2016.